MRI might reveal hidden pancreatic risks in obesity

NCT ID NCT04007640

Terminated Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This study investigates whether MRI can detect early signs of pancreatic damage linked to obesity and metabolic syndrome, which are risk factors for pancreatic cancer. Researchers will compare MRI images with tissue samples from patients undergoing pancreatic surgery, as well as from healthy volunteers and obese individuals. The goal is to develop better screening tools to catch precancerous changes early.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MRI with additional sequences
What this could lead to: If successful, this could lead to better imaging tools for early detection of pancreatic cancer in people with obesity or metabolic syndrome.
What could go wrong: This is an early-stage study with a small number of participants, so results may not apply broadly. MRI findings may not perfectly match actual tissue changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PANCREATIC LESIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign neoplasm of pancreas diabetes mellitus malignant pancreatic neoplasm metabolic syndrome X Obesity pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATIC CANCER

Contacts and locations

Locations

Hôpital Beaujon

Clichy, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.